» Articles » PMID: 23133651

The β1-subunit of Na(v)1.5 Cardiac Sodium Channel is Required for a Dominant Negative Effect Through α-α Interaction

Overview
Journal PLoS One
Date 2012 Nov 8
PMID 23133651
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Brugada syndrome (BrS) is an inherited autosomal dominant cardiac channelopathy. Several mutations on the cardiac sodium channel Na(v)1.5 which are responsible for BrS lead to misfolded proteins that do not traffic properly to the plasma membrane. In order to mimic patient heterozygosity, a trafficking defective mutant, R1432G was co-expressed with Wild Type (WT) Na(v)1.5 channels in HEK293T cells. This mutant significantly decreased the membrane Na current density when it was co-transfected with the WT channel. This dominant negative effect did not result in altered biophysical properties of Na(v)1.5 channels. Luminometric experiments revealed that the expression of mutant proteins induced a significant reduction in membrane expression of WT channels. Interestingly, we have found that the auxiliary Na channel β(1)-subunit was essential for this dominant negative effect. Indeed, the absence of the β(1)-subunit prevented the decrease in WT sodium current density and surface proteins associated with the dominant negative effect. Co-immunoprecipitation experiments demonstrated a physical interaction between Na channel α-subunits. This interaction occurred only when the β(1)-subunit was present. Our findings reveal a new role for β(1)-subunits in cardiac voltage-gated sodium channels by promoting α-α subunit interaction which can lead to a dominant negative effect when one of the α-subunits shows a trafficking defective mutation.

Citing Articles

Potassium KCa3.1 channel overexpression deteriorates functionality and availability of channels at the outer cellular membrane.

Bal N, Oblasov I, Ierusalimsky V, Shvadchenko A, Fortygina P, Idzhilova O Sci Rep. 2025; 15(1):4928.

PMID: 39929947 PMC: 11811289. DOI: 10.1038/s41598-025-89097-8.


Cardiac sodium channel complexes and arrhythmia: structural and functional roles of the β1 and β3 subunits.

Salvage S, Jeevaratnam K, Huang C, Jackson A J Physiol. 2022; 601(5):923-940.

PMID: 36354758 PMC: 10953345. DOI: 10.1113/JP283085.


Genomic and Non-Genomic Regulatory Mechanisms of the Cardiac Sodium Channel in Cardiac Arrhythmias.

Daimi H, Lozano-Velasco E, Aranega A, Franco D Int J Mol Sci. 2022; 23(3).

PMID: 35163304 PMC: 8835759. DOI: 10.3390/ijms23031381.


Dominant-Negative Effect of an Brugada Syndrome Variant.

Doisne N, Grauso M, Mougenot N, Clergue M, Souil C, Coulombe A Front Physiol. 2021; 12:661413.

PMID: 34122134 PMC: 8195286. DOI: 10.3389/fphys.2021.661413.


β1 and β3 subunits amplify mechanosensitivity of the cardiac voltage-gated sodium channel Nav1.5.

Maroni M, Korner J, Schuttler J, Winner B, Lampert A, Eberhardt E Pflugers Arch. 2019; 471(11-12):1481-1492.

PMID: 31728700 DOI: 10.1007/s00424-019-02324-w.


References
1.
Keller D, Rougier J, Kucera J, Benammar N, Fressart V, Guicheney P . Brugada syndrome and fever: genetic and molecular characterization of patients carrying SCN5A mutations. Cardiovasc Res. 2005; 67(3):510-9. DOI: 10.1016/j.cardiores.2005.03.024. View

2.
Catterall W . Molecular properties of voltage-sensitive sodium channels. Annu Rev Biochem. 1986; 55:953-85. DOI: 10.1146/annurev.bi.55.070186.004513. View

3.
Baroudi G, Pouliot V, Denjoy I, Guicheney P, Shrier A, Chahine M . Novel mechanism for Brugada syndrome: defective surface localization of an SCN5A mutant (R1432G). Circ Res. 2001; 88(12):E78-83. DOI: 10.1161/hh1201.093270. View

4.
Watanabe H, Koopmann T, Scouarnec S, Yang T, Ingram C, Schott J . Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J Clin Invest. 2008; 118(6):2260-8. PMC: 2373423. DOI: 10.1172/JCI33891. View

5.
Brugada J, Brugada R, Brugada P . Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease. Circulation. 1998; 97(5):457-60. DOI: 10.1161/01.cir.97.5.457. View